Publicaties

Blot K., Vogelaers D. et al., Gram-negative central line-associated bloodstream infection incidence peak during the summer: a national seasonality cohort study, Sci Rep. 2022 Mar 25;12(1):5202

Camidge DR., Demedts I., et al., A Randomized, Open-Label Phase II Study Evaluating Emibetuzumab Plus Erlotinib and Emibetuzumab Monotherapy in MET Immunohistochemistry Positive NSCLC Patients with Acquired Resistance to Erlotinib, Clin Lung Cancer. 2022 Mar 17:S1525-7304(22)00039-0

Claesen Z., Ravelingien A., et al., Niet-invasieve prenatale testen: detecteren van numerieke afwijkingen van geslachtschromosomen. Is het wenselijk om deze informatie mee te delen aan zwangere vrouwen? Tijdschrift voor Geneeskunde en Gezondheidszorg 2022; 4(78):274-282

Cruyt L., Mutluoglu M., Vandenbulcke R., Rosseel F., Gryspeerdt S., De Smet K., Hold before sacrificing the testis! There may be another possibility. A case of tuberculosis epididymo-vasitis, Arch Esp Urol. 2021 Oct;74(8):808-810

D'Haens GR, Baert F., et al., Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results, Gastroenterology. 2022 Feb 3:S0016-5085(22)00099-3

Degroote S., Vandekerckhove L., Vogelaers D., Vanden Bulcke C., Patient-reported outcomes among people living with HIV on single- versus multi-tablet regimens: Data from a real-life setting, PLoS One. 2022 Jan 13;17(1):e0262533

De Melio J., De Smet K., Gryspeerdt S., Vandenbulcke R. et al., Bilateral pulmonary sequestration complicated with a bibasal pneumonia in an adult patient, Radiol Case Rep. 2020 Dec 17;16(3):457-460

Giacobbe DR., Lormans P. et al., Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients, J Clin Microbiol. 2022 Apr 20;60(4):e0229821

Jiang X., Acou W-A. et al., Adjunctive Left Atrial Posterior Wall Isolation in Treating Atrial Fibrillation: Insight From a Large Secondary-Analysis, J Am Coll Cardiol EP, Mar 30, 2022

Konopleva MY., Deeren D., et al., Idasanutlin Plus Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia: Results of the MIRROS Trial, Blood Adv. 2022 Apr 12:bloodadvances.2021006303

Manivannan S., Roelens F., et al., De novo FZR1 loss-of-function variants cause developmental and epileptic encephalopathies, Brain 2021 Nov 11

Mutluoglu M., Marrannes J., Boel K., De Smet K., Penile Girth Enlargement: do not try it at home, Int J Impot Res. 2022 Jan;34(1):108-110

Mutluoglu M., Van Robaeys F., Gryspeerdt S., De Smet K., Non-traumatic intrathoracic herniation of the caudate lobe, BMJ Case Rep. 2022 Mar 9;15(3):e248955

Mutluoglu M., Cruyt L., Thomas R., De Smet K., Atypical presentation of subchondral cysts in the femoral head, BMJ Case Rep. 2021 Nov 30;14(11):e246098

Noreillie M.-A., Dedeurwaerdere F., Jijo J., Al Hanini S. Marolleau F., Abdominal pain in covid times: time to think twice, Acta Gastro-enterologica Belgica 2022

Pape E., Pattyn P. et al., The trajectory of hope and loneliness in rectal cancer survivors with major low anterior resection syndrome ; A qualitative study, European journal of oncology nursing . December 2021

Rijneveld AW., Deeren D. et al., Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial, Blood Adv. 2021 Dec 9:bloodadvances.2021005624

Rombauts M., Duinslaeger E., Peers K., Kiekens C., Jumping stump phenomenon: a case report. Prosthet Orthot Int. 2022;46(2):191-194

Schreiber S. , Baert F. et al., Review article: randomised controlled trials in inflammatory bowel disease-common challenges and potential solutions, Aliment Pharmacol Ther. 2022 Mar;55(6):658-669

Van Bockstal M., Dedeurwaerdere F. et al., The Use of Pan-Tropomyosin Receptor Kinase Immunohistochemistry as a Screening Tool for the Detection of Neurotrophic Tropomyosin-Related Kinase Fusions: Real-World Data from a National Multicentric Retrospective Study, Pathobiology 2022

Van Daele R., Lormans P. et al., Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA-FLU study, Mycoses. 2022 Apr 19

Van der Linden M., Demedts I., Himpe U., Dedeurwaerdere F., et al., Application of an Ultrasensitive NGS-Based Blood Test for the Diagnosis of Early-Stage Lung Cancer: Sensitivity, a Hurdle Still Difficult to Overcome, Cancers 2022, 14(8), 2031

Vanderstichele A., et al., Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer, Gynecol Oncol. 2022 Apr;165(1):14-22

Van Geel N., Depaepe L., et al., Assessing the dynamic changes in vitiligo: reliability and validity of the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS), J Eur Acad Dermatol Venereol. 2022 Apr 10

Vangheluwe T., Van Hoecke F., Dumoulin A., Vogelaers D., Broad-spectrum azoles and flucloxacillin: a dangerous match, Eur J Clin Microbiol Infect Dis. 2022 Jan;41(1):153-154

Vanhauwaert D., Pinson H., Sweldens C., Du Four S., et al., Quality indicators in neuro-oncology: Review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey, J Neurooncol. 2022 Apr;157(2):365-376

Vanmarcke A., Lormans P., Vandewaeter C., Status Epilepticus Following Intrathecal Administration of Bupivacaine: A Case Report, J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096221090841

Vermeir P., Vogelaers D. et al., Epidemiology and organisation of care in medically unexplained symptoms: A systematic review with a focus on cultural diversity and migrants, Int J Clin Pract. 2021 Dec;75(12):e14855

Veys K., et al., Urine-Derived Kidney Progenitor Cells in Cystinosis, Cells. 2022 Apr 6;11(7):1245

Zeiser R., Deeren D., et al., Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial, Lancet Haematol. 2022 Jan;9(1):e14-e25